Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Adipose-derived stromal stem cells (ASCs) as a new regenerative immediate therapy combating coronavirus (COVID-19)-induced pneumonia
Pietro Gentile, Aris Sterodimas
Expert Opinion on Biological Therapy (2020) Vol. 20, Iss. 7, pp. 711-716
Open Access | Times Cited: 79

Showing 1-25 of 79 citing articles:

Stem cell-based therapy for human diseases
Duc M. Hoang, Phuong T. Pham, Trung Q. Bach, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 617
Overview of current adipose-derived stem cell (ADSCs) processing involved in therapeutic advancements: flow chart and regulation updates before and after COVID-19
Loubna Mazini, Mohamed Ezzoubi, Gabriel Malka
Stem Cell Research & Therapy (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 175
Adipose-derived mesenchymal stromal cells for the treatment of patients with severe SARS-CoV-2 pneumonia requiring mechanical ventilation. A proof of concept study
Fermín Sánchez‐Guijo, Mariano García‐Arranz, Miriam López-Parra, et al.
EClinicalMedicine (2020) Vol. 25, pp. 100454-100454
Open Access | Times Cited: 163
The heterogeneity of mesenchymal stem cells: an important issue to be addressed in cell therapy
Jingxuan Li, Zewen Wu, Li Zhao, et al.
Stem Cell Research & Therapy (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 56
Mesenchymal stem cell (MSC)-derived exosomes as a cell-free therapy for patients Infected with COVID-19: Real opportunities and range of promises
Leila Rezakhani, Ali Fatahian Kelishadrokhi, Arghavan Soleimanizadeh, et al.
Chemistry and Physics of Lipids (2020) Vol. 234, pp. 105009-105009
Open Access | Times Cited: 74
Mesenchymal stem cells and exosome therapy for COVID-19: current status and future perspective
Ashim Gupta, Shivaji Kashte, Manu Gupta, et al.
Human Cell (2020) Vol. 33, Iss. 4, pp. 907-918
Open Access | Times Cited: 73
Adipose mesenchymal stem cells combined with platelet-rich plasma accelerate diabetic wound healing by modulating the Notch pathway
Nesrine Ebrahim, Arigue A. Dessouky, Ola Mostafa, et al.
Stem Cell Research & Therapy (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 67
Adipose Stem Cells in Regenerative Medicine: Looking Forward
Sara Al‐Ghadban, Maria Artiles, Bruce A. Bunnell
Frontiers in Bioengineering and Biotechnology (2022) Vol. 9
Open Access | Times Cited: 63
Immunomodulatory properties of mesenchymal stromal/stem cells: The link with metabolism
Hanyue Li, Hongwei Dai, Jie Li
Journal of Advanced Research (2022) Vol. 45, pp. 15-29
Open Access | Times Cited: 48
Potential application of mesenchymal stem cells and their exosomes in lung injury: an emerging therapeutic option for COVID-19 patients
Sara Al‐Khawaga, Essam M. Abdelalim
Stem Cell Research & Therapy (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 69
A synergistic role of convalescent plasma and mesenchymal stem cells in the treatment of severely ill COVID-19 patients: a clinical case report
Hongbing Peng, Tiefeng Gong, Xiaoying Huang, et al.
Stem Cell Research & Therapy (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 62
Research progress on Mesenchymal Stem Cells (MSCs), Adipose-Derived Mesenchymal Stem Cells (AD-MSCs), Drugs, and Vaccines in Inhibiting COVID-19 Disease
Pietro Gentile, Aris Sterodimas, Jacopo Pizzicannella, et al.
Aging and Disease (2020) Vol. 11, Iss. 5, pp. 1191-1191
Open Access | Times Cited: 62
Exosomes from adipose tissue-derived mesenchymal stem cells ameliorate histone-induced acute lung injury by activating the PI3K/Akt pathway in endothelial cells
Yukie Mizuta, Tomohiko Akahoshi, Jie Guo, et al.
Stem Cell Research & Therapy (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 59
Mesenchymal stem cell immunomodulation: In pursuit of controlling COVID-19 related cytokine storm
Na Song, Hiroaki Wakimoto, Filippo Rossignoli, et al.
Stem Cells (2021) Vol. 39, Iss. 6, pp. 707-722
Open Access | Times Cited: 55
Mesenchymal stem cell-based therapy and exosomes in COVID-19: current trends and prospects
Mai Abdelgawad, Nourhan Saied Bakry, Ahmed A. Farghali, et al.
Stem Cell Research & Therapy (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 42
Monoclonal antibody therapies in the management of SARS-CoV-2 infection
Enrique Míguez‐Rey, Dasom Choi, Seungmin Kim, et al.
Expert Opinion on Investigational Drugs (2022) Vol. 31, Iss. 1, pp. 41-58
Open Access | Times Cited: 37
Translational development of ABCB5+ dermal mesenchymal stem cells for therapeutic induction of angiogenesis in non-healing diabetic foot ulcers
Andreas Kerstan, Kathrin Dieter, Elke Niebergall‐Roth, et al.
Stem Cell Research & Therapy (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 37
The investigation of the efficacy and safety of stromal vascular fraction in the treatment of nanofat-treated acne scar: a randomized blinded controlled clinical trial
Elham Behrangi, Sepideh Moradi, Mohammadreza Ghassemi, et al.
Stem Cell Research & Therapy (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 29
Efficacy of topical and systemic transplantation of mesenchymal stem cells in a rat model of diabetic ischemic wounds
Jianxin Yan, Jiaji Liang, Yingxuan Cao, et al.
Stem Cell Research & Therapy (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 34
Hair Loss and Telogen Effluvium Related to COVID-19: The Potential Implication of Adipose-Derived Mesenchymal Stem Cells and Platelet-Rich Plasma as Regenerative Strategies
Pietro Gentile
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 16, pp. 9116-9116
Open Access | Times Cited: 27
Rescuing emergency cases of COVID-19 patients: An intelligent real-time MSC transfusion framework based on multicriteria decision-making methods
M. A. Alsalem, O. S. Albahri, A. A. Zaidan, et al.
Applied Intelligence (2022) Vol. 52, Iss. 9, pp. 9676-9700
Open Access | Times Cited: 25
Adipose-derived stem cells combined with platelet-rich plasma enhance wound healing in a rat model of full-thickness skin defects
Xuejun Ni, Xiuying Shan, Lili Xu, et al.
Stem Cell Research & Therapy (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 32
The time to offer treatments for COVID-19
Binh Ngo, Paul E. Marik, Pierre Kory, et al.
Expert Opinion on Investigational Drugs (2021) Vol. 30, Iss. 5, pp. 505-518
Open Access | Times Cited: 31
Human Dental Pulp Stem Cells Modulate Cytokine Production in vitro by Peripheral Blood Mononuclear Cells From Coronavirus Disease 2019 Patients
Stefania Croci, Martina Bonacini, Giovanni Dolci, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 8
Open Access | Times Cited: 28
Safety and efficacy of mesenchymal stem cells in severe/critical patients with COVID-19: A systematic review and meta-analysis
Weiqi Yao, Haibo Dong, Ji Qi, et al.
EClinicalMedicine (2022) Vol. 51, pp. 101545-101545
Open Access | Times Cited: 21
Page 1 - Next Page

Scroll to top